|
PPP1R8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.077500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.938400E-02 |
| Normal-vs-Stage2 |
4.098500E-03 |
| Normal-vs-Stage3 |
1.229530E-02 |
| Normal-vs-Stage4 |
6.565500E-04 |
| Stage1-vs-Stage2 |
1.371630E-01 |
| Stage1-vs-Stage3 |
3.345600E-01 |
| Stage1-vs-Stage4 |
4.595900E-02 |
| Stage2-vs-Stage3 |
5.014800E-01 |
| Stage2-vs-Stage4 |
9.732000E-01 |
| Stage3-vs-Stage4 |
3.806800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.234180E-02 |
| Normal-vs-AfricanAmerican |
5.437400E-01 |
| Normal-vs-Asian |
2.960200E-02 |
| Caucasian-vs-AfricanAmerican |
2.522200E-01 |
| Caucasian-vs-Asian |
9.259200E-01 |
| AfricanAmerican-vs-Asian |
2.437800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.757400E-03 |
| Normal-vs-Female |
1.150410E-02 |
| Male-vs-Female |
8.929200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.779600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.076200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.834300E-04 |
| Normal-vs-Age(81-100Yrs) |
3.476300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.495800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.072500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.969400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.190590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.465200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.853800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.985600E-01 |
| Classical-VS-Follicular |
1.200590E-03 |
| Classical-VS-Other |
6.581600E-01 |
| Classical-VS-Normal |
1.046590E-01 |
| Tall-VS-Follicular |
2.525400E-01 |
| Tall-VS-Other |
9.354000E-01 |
| Tall-VS-Normal |
5.128300E-02 |
| Follicular-VS-Other |
5.006800E-01 |
| Follicular-VS-Normal |
5.350200E-04 |
| Other-VS-Normal |
3.104400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.499200E-03 |
| Normal-vs-N1 |
1.160600E-03 |
| N0-vs-N1 |
3.168600E-01 |
|
|
